C. Papagiannopoulos

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation

H. Kampinga, Wei-Guo Zhu, Jing Yang, 2021, Human molecular genetics.

The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co‐exposure with chemical inducers in culture

Konstantinos A Kyritsis, M. Akrivou, I. Vizirianakis, 2021, Journal of biological research.

Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study

Konstantinos A Kyritsis, I. Vizirianakis, C. Papagiannopoulos, 2020, Frontiers in Oncology.

Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine

L. Angelis, A. Papa, G. Sianos, 2022, Cells.

Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies

Konstantina Psatha, M. Aivaliotis, I. Vizirianakis, 2022, Frontiers in Molecular Biosciences.

miR-16-5p Promotes Erythroid Maturation of Erythroleukemia Cells by Regulating Ribosome Biogenesis

I. Vizirianakis, C. Papagiannopoulos, Nikoleta F Theodoroula, 2021, Pharmaceuticals.

A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial

L. Angelis, A. Papa, G. Sianos, 2022, Frontiers in Cardiovascular Medicine.